Cargando…
Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes
BACKGROUND: Onchocerciasis is found predominantly in Africa where large scale vector control started in 1974. Registration and donation of ivermectin by Merck & Co in 1987 enabled mass treatment with ivermectin in all endemic countries in Africa and the Americas. Although elimination of onchocer...
Autores principales: | Dadzie, Yankum, Amazigo, Uche V., Boatin, Boakye A., Sékétéli, Azodoga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029117/ https://www.ncbi.nlm.nih.gov/pubmed/29966535 http://dx.doi.org/10.1186/s40249-018-0446-z |
Ejemplares similares
-
The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
por: Dadzie, Yankum, et al.
Publicado: (2019) -
Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019) -
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
por: Tekle, Afework Hailemariam, et al.
Publicado: (2012) -
Final report of the Conference on the eradicability of Onchocerciasis
por: Dadzie, Yankum, et al.
Publicado: (2003) -
Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
por: Cupp, Ed, et al.
Publicado: (2019)